STOCK TITAN

Cryomass Technologies Inc. - CRYM STOCK NEWS

Welcome to our dedicated page for Cryomass Technologies news (Ticker: CRYM), a resource for investors and traders seeking the latest updates and insights on Cryomass Technologies stock.

CryoMass Technologies Inc. (symbol: CRYM) is a pioneering entity in the field of cryogenic botanical refinement systems, dedicated to enhancing the efficiency and yield of cannabinoid extraction processes. The company's flagship product, the CryoSift Separator™, utilizes patented cryogenic techniques to isolate and preserve high-value cannabis and hemp trichomes.

The company's recent licensing agreement with RubberRock Inc., co-founded by renowned extractor Brad Robertson, underscores its commitment to innovation. This partnership aims to scale the use of CryoSift™ for large-scale cannabinoid production. The agreement guarantees CryoMass a minimum of $3 million in annual royalties, with royalty rates set at 25% of gross revenue from products utilizing CryoSift™.

Financially, CryoMass has secured a non-dilutive financing agreement with CRYM Co-Invest GP, enabling the sale of up to five CryoSift Separator™ units for $6 million. This arrangement allows for the wider deployment of their technology while maintaining shareholder value. The recent sale of a unit to LEEF Brands, Inc. for $1.2 million marks a significant milestone in their commercialization efforts.

Under the leadership of CEO Christian Noël, CryoMass continues to strategically select partners to deploy its technology globally. The company has fielded over 200 inquiries from various countries and states, actively engaging with numerous prospects.

CryoMass is traded on the OTC QB market and continues to innovate in the cannabis industry, aiming to transform post-harvest methods worldwide. For more information, interested parties can contact the company at investors@cryomass.com or by phone at 303-222-8092.

Rhea-AI Summary

CryoMass Technologies announced the sale of its second CryoSift Separator™ for $1.2 million to LEEF Brands, a major vertically integrated cannabis company in California. This sale is part of a multi-party Equipment Lease and Non-Exclusive Patent License agreement facilitated by a Non-Dilutive Financing Agreement with CRYM Co-Invest GP. The partnership highlights LEEF's commitment to innovation and efficiency in biomass refinement, aligning with CryoMass's pioneering cryogenic technology. This collaboration is a significant milestone for CryoMass, reinforcing its position in the cannabis industry.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
50.61%
Tags
partnership
-
Rhea-AI Summary

CryoMass Technologies announced the sale of its first CryoSift Separator™ production model for CAD$1.62 million, to be deployed in Canada. The sale is part of a multi-party Equipment Lease and Non-Exclusive Patent License agreement, which will also generate recurring revenue from processing fees. The new modular system dramatically reduces biomass volume by 65% and enhances both performance and versatility. The buyer has 60 days to complete the payment. This marks a significant milestone in CryoMass's growth strategy and aims to introduce its cryogenic technology to Canada's mature cannabis market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20%
Tags
none
-
Rhea-AI Summary
CryoMass Technologies Inc. has reached an agreement with CRYM Co-Invest GP to sell up to five CryoSift Separator™ Units for a total of up to US$6 million. The innovative financing structure provides growth capital to CryoMass while enabling wider deployment of the Company's processing technology. The funding arrangement will be non-dilutive to CryoMass shareholders, while providing a recurring revenue stream from processing fees charged to Clients. Access to capital has been an ongoing challenge for prospective Clients working in the cannabis industry due to federal prohibition.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
32.5%
Tags
none
Rhea-AI Summary
CryoMass signs license agreement with RubberRock Inc. for large-scale cannabinoid production, guaranteeing at least $3 million in annual royalties. CryoMass aims to scale its disruptive technology and increase revenue potential.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.16%
Tags
partnership
-
News
Rhea-AI Summary
CryoMass Technologies Inc. announces successful transition to commercial processing phase with its Trichome Separation Beta unit. The company has achieved a major milestone by designing and constructing an industrial-scale Beta system. CryoMass expects to receive scheduled payments from RedTape over the next 12 months and is engaged in discussions for market expansion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.38%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.35%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.05%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.49%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.49%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.28%
Tags
management

FAQ

What does CryoMass Technologies Inc. do?

CryoMass Technologies Inc. develops and licenses cryogenic refinement systems for cannabis and hemp, notably the CryoSift Separator™.

What is the CryoSift Separator™?

The CryoSift Separator™ is a cryogenic device designed to isolate high-value trichomes from cannabis and hemp, enhancing extraction efficiency.

Who are CryoMass's recent partners?

CryoMass recently partnered with RubberRock Inc. to scale cannabinoid production using CryoSift™ and signed an agreement with LEEF Brands, Inc.

What are the financial benefits of CryoMass's recent agreements?

CryoMass's agreements guarantee at least $3 million in annual royalties from RubberRock and a non-dilutive $6 million financing arrangement with CRYM Co-Invest GP.

How does CryoMass's technology benefit cultivators and processors?

CryoMass's technology reduces biomass volume by up to 80%, lowering storage and transportation costs while preserving potency and terpenes.

What are CryoMass's future plans?

CryoMass plans to deploy additional CryoSift units in strategic regions and continues to engage with new partners globally.

Where is CryoMass Technologies Inc. traded?

CryoMass Technologies Inc. is traded on the OTC QB market under the symbol CRYM.

How can I contact CryoMass Technologies Inc.?

You can contact CryoMass Technologies Inc. via email at investors@cryomass.com or by phone at 303-222-8092.

What is the significance of the partnership with LEEF Brands, Inc.?

The partnership with LEEF Brands, Inc. integrates CryoMass's CryoSift technology into one of California's largest cannabis companies, enhancing efficiency and market reach.

What challenges does CryoMass face in the cannabis industry?

CryoMass faces challenges such as regulatory restrictions and limited access to traditional financing due to federal cannabis laws.

Cryomass Technologies Inc.

OTC:CRYM

CRYM Rankings

CRYM Stock Data

8.75M
164.79M
17.05%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Carson City